Disclosure of business profit before R&D investment
First written in FY2019-Q3. 17 of 24 entries say "Restated". Latest entry: 2026-07-31.
No other company in this theme has enough history to compare yet.
- 2026-07-31AdvancedEarnings
「Business profit before investment in research and development expenses amounted to ¥452,753 million, up 12.6% year on year.」
The company disclosed a year-on-year increase in business profit before investment in research and development expenses. - FY2026-H1AdvancedAnnual report
「Business profit before investment in research and development expenses amounted to ¥452,753 million, up 12.6% year on year.」
Business profit before R&D expenses increased 12.6% year on year to ¥452,753 million, indicating an improvement in earnings power before deducting R&D investment. - 2026-04-28AdvancedEarnings
「Business profit before investment in research and development expenses amounted to ¥205,120 million, up 1.9% year on year.」
The company disclosed a year-on-year increase in earning power before deducting research and development investment. - FY2025AdvancedAnnual report
「Business profit before R&D expenses was ¥798,968 million, up 7.3%.」
The indicator of earnings power before deducting R&D investment continued to be disclosed, and was ¥798,968 million, up 7.3% year on year. - FY2025-H1AdvancedAnnual report
「Business profit before R&D expenses was ¥402,125 million, up 12.5%.」
Business profit before R&D expenses increased 12.5% year on year, indicating an improvement in earnings power before deducting R&D investment. - FY2024AdvancedAnnual report
「Business profit before R&D expenses was ¥744,696 million, up 20.0%.」
The indicator of earnings power before deducting R&D investment continued to be disclosed, and was ¥744,696 million, up 20.0% year on year. - FY2024-H1RestatedAnnual report
「Business profit before R&D expenses was ¥357,571 million, up 20.3%.」
Business profit before R&D expenses continued to be disclosed, and was ¥357,571 million, up 20.3% year on year. - FY2024-Q1RestatedAnnual report
「Business profit before R&D expenses 141,649 161,352 19,703 13.9%」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥161,352 million in the first quarter, up 13.9% year on year. - FY2023-Q3RestatedAnnual report
「Business profit before R&D expenses 319,460 474,120 154,660 48.4%」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥474,120 million, up 48.4% year on year. - FY2023-Q2RestatedAnnual report
「Business profit before R&D expenses was ¥297,150 million, up 46.1%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and increased 46.1% year on year. - FY2023-Q1RestatedAnnual report
「Business profit before R&D expenses was ¥141,649 million, up 39.1%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and increased 39.1% year on year. - FY2022RestatedAnnual report
「Business profit before R&D expenses was ¥450,147 million, up 15.6%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and increased 15.6% year on year. - FY2022-Q3RestatedAnnual report
「Business profit before R&D expenses was ¥319,460 million, essentially unchanged from the same period of the previous year, up 0.3%.」
The indicator of earnings power before deducting R&D expenses continues to be disclosed. - FY2022-Q2RestatedAnnual report
「Business profit before R&D expenses 207,191 203,334 △3,856 △1.9%」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥203,334 million for the six months ended the second quarter, down 1.9% year on year. - FY2022-Q1RestatedAnnual report
「Business profit before R&D expenses 97,511 101,815 4,304 4.4%」
Business profit before R&D expenses continued to be disclosed, and was ¥101,815 million in the first quarter, up 4.4% year on year. - FY2021RestatedAnnual report
「Business profit before R&D expenses was ¥389,427 million, down 10.2%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥389,427 million in fiscal 2021, down 10.2% year on year. - FY2021-Q3RestatedAnnual report
「Business profit before R&D expenses was ¥318,384 million, down 8.2%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥318,384 million in the nine months ended the third quarter on a consolidated basis, down 8.2% year on year. - FY2021-Q1RestatedAnnual report
「Business profit before R&D expenses 104,781 97,511 △7,270 △6.9%」
Business profit before R&D expenses continued to be disclosed, and was ¥97,511 million in the first quarter, down 6.9% year on year. - FY2020RestatedAnnual report
「Business profit before R&D expenses was ¥433,729 million, up 7.6%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥433,729 million, up 7.6% year on year. - FY2020-Q3RestatedAnnual report
「Business profit before R&D expenses was ¥346,723 million, up 11.8%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥346,723 million, up 11.8% year on year. - FY2020-Q2RestatedAnnual report
「Business profit before R&D expenses was ¥223,155 million, up 12.9%.」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and increased 12.9% year on year. - FY2020-Q1RestatedAnnual report
「Business profit before R&D expenses 84,407 104,781 20,374 24.1%」
The indicator of earnings power before deducting R&D expenses continued to be disclosed, and was ¥104,781 million, up 24.1% year on year. - FY2019RestatedAnnual report
「Business profit before R&D expenses was ¥402,957 million, up 28.4%.」
The indicator of earnings power before deducting R&D expenses was also disclosed for the full fiscal year, at ¥402,957 million, up 28.4% year on year. - FY2019-Q3First statedAnnual report
「Business profit before R&D expenses 237,117 310,265 73,148 30.8%」
The performance table includes business profit before R&D expenses, calculated by adding R&D expenses to business profit, to show earnings power before deducting R&D investment.